Finanical Statements
October Pharma (OCPH.CA) Reports its Financial Results for the Period from 01/01/2026 to 30/06/2026
Published at 16 August 2026 at 07:27October PharmaRelated stock:October Pharma stockAll October Pharma disclosures
Disclosure summary
Company Name: October Pharma
ISIN Code: EGS380R1C018
Currency: Egyptian Pound
F/S Period: From 01/01/2026 to 30/06/2026
Net profit: 143,835,077
F/S Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 92,769,098
Audit Status: Reviewed
Source: October Pharma
The Financial Statements (7,954 KB)
ISIN Code: EGS380R1C018
Currency: Egyptian Pound
F/S Period: From 01/01/2026 to 30/06/2026
Net profit: 143,835,077
F/S Period: From 01/01/2025 to 30/06/2025
Net Comparative profit: 92,769,098
Audit Status: Reviewed
Source: October Pharma
The Financial Statements (7,954 KB)